Delivery Order SPE2DB20D7066-SPE2DB25FC2WE

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,786.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a period of performance through March 25, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $47,827.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a prescription medication. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award, valued at $51,990.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a period of performance through February 25, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,133.60 firm fixed-price delivery order contract is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,084.45 fixed-price delivery order contract is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a performance period ending on June 27, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $12,499.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a completion date of February 4, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $29,933.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC), which has a total potential value of $999,999,999 and runs through November 2026. The contract covers the procurement of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, to support military healthcare...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,764.87, is a delivery order for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This federal contract award, valued at $7,829.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of JARDIANCE 25 MG TABLET 90S, a medical product, with a completion date of January 13, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $13,808.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, to support federal healthcare programs. The award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC2WE
    Delivery Order

This federal contract award, valued at $11,912.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, and has an ultimate completion date of April 4, 2025.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

This contract award does not have a set-aside designation, indicating open competition.

Generated 7/3/25, 3:05 PM